结直肠癌患者手术部位感染的病原菌分析

Distribution of pathogenic bacteria causing surgical site infections in patients with colorectal cancer

  • 摘要: 目的 分析结直肠癌患者手术部位感染的病原菌分布及临床特征,为合理制定感染预防控制方案提供客观依据。方法 选取2013年1月-2014年12月200例行根治性手术的结直肠癌患者作为研究对象,调查其手术部位感染率、感染部位、病原菌分布,病原菌鉴定应用VITEK-2 COMPACT型全自动微生物鉴定系统进行;并分析发生感染的相关危险因素。结果 共有45例患者发生手术部位感染,感染率为22.5%;感染部位以浅部切口感染居多,占80.0%;患有糖尿病、体质量指数高、手术时间长及Dukes 分期等为手术部位感染的相关因素;手术部位感染患者中共分离出57株病原菌,革兰阴性菌占80.7%、革兰阳性菌占19.3%,以大肠埃希菌、铜绿假单胞菌和表皮葡萄球菌检出最多,分别占56.1%、8.7%和7.0%。结论 手术部位感染的相关因素较多,临床医师应针对高危因素进行有效干预,并选取敏感性抗菌药物进行抗感染治疗,以确保治疗效果。

     

    Abstract: OBJECTIVE To investigate the distribution of pathogens causing surgical site infections in patients with colorectal cancer and analyze the clinical characteristics so as to provide objective basis for development of and prevention and control programs. METHODS A total of 200 patients with colorectal cancer who underwent the radical surgery from Jan 2013 to Dec 2014 were recruited as the study objects, then the incidence of surgical site infections, infection sites, and distribution of pathogens were investigated, the pathogens were identified by using VITEK-2 COMPACT automatic microbial identification system, and the related risk factors for the infections were observed. RESULTS The surgical site infections occurred in totally 45 patients, with the infection rate 22.5%; the patients with superficial incision infections accounted for 80.0%. The related factors for the surgical site infections included the diabetic mellitus, high body mass index, long operation duration, and Dukes stage. Totally 57 strains of pathogens were isolated from the patients with surgical site infections, of which 80.7% were gram-negative bacteria, 19.3% were gram-positive bacteria; the Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus epidermidis were dominant among the isolated pathogens, accounting for 56.1%, 8.7%, and 7.0%, respectively. CONCLUSION There are a variety of factors associated with the surgical site infections. It is necessary for the clinician to take effective interventions aiming at the high risk factors and choose sensitive antibiotics for treatment of the infections so as to ensure the therapeutic effect.

     

/

返回文章
返回